|

HC-7366 Clinical Trials

2 actively recruiting trials across 2 locations

Pipeline

Phase 1: 2

Top Sponsors

  • M.D. Anderson Cancer Center1
  • HiberCell, Inc.1

Indications

  • Cancer2
  • Renal Cell Carcinoma1
  • Acute Myeloid Leukemia1

Tucson, Arizona1 trial

A Study of HC-7366 in Combination With Belzutifan (WELIREG™) in Patients With Renal Cell Carcinoma

University of Arizona Cancer Center

Phase 1

Houston, Texas1 trial

Phase I Study of HC-7366 for Acute Myeloid Leukemia

MD Anderson Cancer Center

Phase 1

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.